AML probability of SRSF2 and SF3B1 splicing genes in MDS patients without harboring ring sideroblast. The leukemia free survival in patients with SRSF2 mutation was inferior to the WT (p=0.001). However, no statistical significance of the leukemic transformation was observed in the patients with SF3B1 mutation (p=0.247).